0 оценок0% нашли этот документ полезным (0 голосов)
46 просмотров1 страница
Chemax Inc. manufactures pharmaceuticals and medical instruments. It recently developed a new line of antihistamine drugs that has exceeded sales and profit expectations, accounting for 10% of total sales and 12% of operating income. Management is concerned about disclosing information about this product line due to competitive risks but is unsure how reporting standards apply.
Исходное описание:
Оригинальное название
Chemax Inc Manufactures a Wide Variety of Pharmaceuticals Medical Instruments
Chemax Inc. manufactures pharmaceuticals and medical instruments. It recently developed a new line of antihistamine drugs that has exceeded sales and profit expectations, accounting for 10% of total sales and 12% of operating income. Management is concerned about disclosing information about this product line due to competitive risks but is unsure how reporting standards apply.
Chemax Inc. manufactures pharmaceuticals and medical instruments. It recently developed a new line of antihistamine drugs that has exceeded sales and profit expectations, accounting for 10% of total sales and 12% of operating income. Management is concerned about disclosing information about this product line due to competitive risks but is unsure how reporting standards apply.
(answered) Chemax Inc manufactures a wide variety of
pharmaceuticals medical instruments
Chemax Inc. manufactures a wide variety of pharmaceuticals, medical instruments, and other medical supplies. Eighteen months ago the company developed and began to market a new product line of antihistamine drugs under various trade names. Sales and profitability of this product line during the curr GET THE ANSWER>> https://solutionlly.com/downloads/chemax-inc-manufactures-a-wide- variety-of-pharmaceuticals-medical-instruments Chemax Inc. manufactures a wide variety of pharmaceuticals, medical instruments, and other medical supplies. Eighteen months ago the company developed and began to market a new product line of antihistamine drugs under various trade names. Sales and profitability of this product line during the current fiscal year greatly exceeded management's expectations. The new product line will account for 10 percent of the company's total sales and 12 percent of the company's operating income for the fiscal year ending June 30, 20X0. Management believes sales and profits will be significant for several years. Chemax is concerned that its market share and competitive position could suffer if it discloses the volume and profitability of its new product line in its annual financial statements. Management is not sure how ASC 280 applies in this case.Requireda. What is the purpose of requiring segment information in financial statements?b. Identify and explain the factors that should be considered when attempting to decide how products should be grouped to determine a single business segment.c. What options, if any, does Chemax Inc. have with the disclosure of its new antihistamine product line? Explain your answer.View Solution: Chemax Inc manufactures a wide variety of pharmaceuticals medical instruments GET THE ANSWER>> https://solutionlly.com/downloads/chemax-inc-manufactures-a-wide- variety-of-pharmaceuticals-medical-instruments